查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654145

电泳市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2025-2030 年

Electrophoresis Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

电泳市场规模及趋势

预计 2024 年全球电泳市场规模为 32.9 亿美元，2025 年至 2030 年复合年增长率为 5.62%。

市场成长的动力在于对先进诊断工具的需求不断增长、对生物技术和医学研究的投资不断增加以及对高效蛋白质和核酸分析的需求不断增长。电泳在药物开发、疾病诊断和研究等各种应用中发挥关键作用，推动了对更复杂、高性能係统的需求。随着生物技术、製药和学术领域继续关注精准医疗和基因研究，对可靠、高效的电泳系统来分离和分析蛋白质、DNA 和 RNA 的需求日益增加。

成长的主要动力之一是技术的不断进步。自动化系统的发展提高了实验效率和可重复性，使得世界各地的实验室越来越多地采用这些技术。此外，高解析度电泳和多路復用功能整合等技术创新提高了这些系统的灵敏度和吞吐量。这些进步使得电泳技术更加普及、用途更加广泛，可以满足临床诊断、学术研究和生物製药等各行业不断变化的需求。例如，安捷伦ProteoAnalyzer系统是一个专为蛋白质分析而设计的先进的自动化平行毛细管电泳平台。这项创新解决方案简化并优化了复杂蛋白质混合物的分析，服务于製药、生物技术、食品分析和学术研究等广泛的产业。

对个人化医疗和标靶治疗的日益关注也是推动市场成长的关键因素。随着医疗保健转向更加个人化治疗，基因检测、生物标记识别和分子诊断已成为医学研究和临床实践的重要组成部分。电泳在这些领域发挥着至关重要的作用，可以精确分离和分析生物分子，用于检测疾病、选择治疗方法和监测治疗结果。预计基因检测需求的不断增长以及电泳在肿瘤学、神经病学和其他治疗领域的日益广泛应用将进一步推动市场成长。

此外，推动电泳产业发展的另一个关键因素是临床实验室和诊断中心的需求不断增加。随着越来越多的临床实验室采用电泳技术进行常规检测和疾病诊断，尤其是在基因检测、血液分析和蛋白质分析领域，市场正在稳步扩大。此外，癌症、糖尿病和心血管疾病等慢性疾病的发生率不断上升，需要精确的分子诊断技术进行早期检测，这也推动了对基于电泳的系统的需求。

此外，製药和生技公司也大力投资研发，以发现新药和治疗方法，帮助开发市场。电泳广泛应用于药物开发过程，从筛检潜在的候选药物到分析蛋白质交互作用和表征治疗性抗体。随着製药公司继续专注于创造创新生技药品，对具有高性能分析和深入蛋白质分析能力的先进系统的需求日益增加。这种增长在电泳对于复杂分子分析至关重要的领域尤其明显，例如单株抗体开发和基因治疗。

然而，先进系统及其维护的高成本是市场成长的主要限制因素。这些系统，尤其是高通量或自动化平台，通常需要大量的资本投资、专门的设备和熟练的人员来操作，这使得预算有限的小型实验室或新兴市场无法使用它们。此外，某些电泳技术的复杂性可能会导致冗长的训练时间，如果管理不善，可能会出现错误。虽然这些系统提供了很高的准确性和效率，但其成本和营运要求可能会限制其采用，尤其是在资源匮乏的环境中。此外，一些地区的技术采用速度缓慢，再加上监管障碍和监管核准的需求，可能会阻碍某些地区的市场成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章电泳市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 电泳市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章 电泳市场：产品特定、估计与趋势分析

  • 全球电泳市场：产品仪表板
  • 全球电泳市场：产品差异分析
  • 全球电泳市场（按产品和收益）
  • 电泳试剂
    • 蛋白质电泳试剂
    • 核酸电泳试剂
  • 电泳系统
    • 凝胶电泳系统
    • 毛细管电泳系统
  • 凝胶成像系统
  • 软体

第 5 章 电泳市场：按应用进行的估计和趋势分析

  • 全球电泳市场：应用仪表板
  • 全球电泳市场：应用趋势分析
  • 全球电泳市场按应用和收益
  • 研究用途
  • 诊断用途
  • 品管和製程检验

第 6 章电泳市场：最终用途、估计和趋势分析

  • 全球电泳市场：最终用途仪表板
  • 全球电泳市场：最终用途变化分析
  • 全球电泳市场按最终用途和收益
  • 学术研究所
  • 製药和生物技术公司
  • 医院和诊断中心
  • 其他的

第 7 章电泳市场：按产品、应用、最终用途和地区进行的估计和趋势分析

  • 区域控制面板
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 2024 年主要企业的市场占有率分析
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies, Inc.
    • Merck KGaA
    • GE Healthcare
    • QIAGEN
    • Lonza Group Ltd.
    • PerkinElmer, Inc.
    • Danaher
    • Harvard Bioscience, Inc.
    • Shimadzu Corporation
Product Code: GVR-4-68040-344-0

Electrophoresis Market Size & Trends:

The global electrophoresis market size was estimated at USD 3.29 billion in 2024 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. The growth of the market is attributed to the increasing demand for advanced diagnostic tools, rising investments in biotechnology and healthcare research, and the growing need for efficient protein and nucleic acid analysis. Electrophoresis plays a critical role in various applications such as drug development, disease diagnosis, and research, driving the demand for more sophisticated, high-throughput systems. As the biotechnology, pharmaceutical, and academic sectors continue to focus on precision medicine and genetic research, the need for reliable and efficient electrophoresis systems to separate and analyze proteins, DNA, and RNA is on the rise.

One of the major drivers of growth is the continuous advancements in technology. The development of automated systems, which enhance the efficiency and reproducibility of experiments, is increasing the adoption of these techniques across laboratories worldwide. Additionally, innovations such as high-resolution electrophoresis and the integration of multiplexing capabilities are improving the sensitivity and throughput of these systems. With these advancements, electrophoresis is becoming more accessible and versatile, capable of meeting the evolving demands of various industries, including clinical diagnostics, academic research, and biopharmaceuticals. For instance, the Agilent ProteoAnalyzer system, which is an advanced automated parallel capillary electrophoresis platform designed for protein analysis. This innovative solution streamlines and optimizes the analysis of complex protein mixtures, serving a wide range of industries including pharmaceuticals, biotechnology, food analysis, and academic research.

The rising emphasis on personalized medicine and targeted therapies is another significant factor driving the growth of the market. As healthcare shifts towards more tailored treatments, genetic testing, biomarker identification, and molecular diagnostics have become essential components of medical research and clinical practice. Electrophoresis plays an integral role in these areas, enabling the precise separation and analysis of biomolecules that can be used for disease detection, treatment selection, and monitoring therapeutic efficacy. The increasing demand for genetic testing and the expanding use of electrophoresis in oncology, neurology, and other therapeutic areas are expected to further fuel market growth.

Furthermore, another key factor driving the electrophoresis industry is the increasing demand from clinical laboratories and diagnostic centers. As more clinical laboratories adopt electrophoresis techniques for routine testing and disease diagnosis, particularly in the areas of genetic testing, blood analysis, and protein profiling, the market is experiencing a steady uptick in adoption. Additionally, the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, which require precise molecular diagnostic techniques for early detection, further contributes to the demand for electrophoresis-based systems.

Moreover, Pharmaceutical and biotechnology companies are also contributing to the market expansion by investing heavily in research and development (R&D) to discover new drugs and therapies. Electrophoresis is widely used in the drug development process, from screening potential drug candidates to analyzing protein interactions and characterizing therapeutic antibodies. As pharmaceutical companies continue to focus on creating innovative biologic drugs, the demand for advanced systems capable of high-throughput analysis and detailed protein profiling is rising. This growth is particularly evident in areas such as monoclonal antibody development and gene therapy, where electrophoresis is crucial for analyzing complex molecules.

However, the high cost associated with advanced systems and their maintenance is a major restraining factor for growth of the market. These systems, particularly high-throughput or automated platforms, often require significant capital investment, specialized equipment, and skilled personnel for operation, making them less accessible to smaller laboratories or those in emerging markets with limited budgets. Additionally, the complexity of certain electrophoresis techniques can result in longer training periods and potential errors if not properly managed. While these systems offer superior accuracy and efficiency, their cost and operational demands can limit adoption, particularly in low-resource settings. Furthermore, the slow pace of technology adoption in some regions, coupled with regulatory barriers and the need for regulatory approvals, can hinder market growth in certain areas.

Global Electrophoresis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global electrophoresis market report based on product, application, end Use, and region.

  • Product Outlook (Revenue, USD Million; 2018 - 2030)
  • Electrophoresis Reagents
    • Protein Electrophoresis Reagents
    • Nucleic Acid Electrophoresis Reagents
  • Electrophoresis Systems
    • Gel Electrophoresis Systems
    • Capillary Electrophoresis Systems
  • Gel Documentation Systems
  • Software
  • Application Outlook (Revenue, USD Million; 2018 - 2030)
  • Research Applications
  • Diagnostics Applications
  • Quality Control and Process Validation
  • End Use Outlook (Revenue, USD Million; 2018 - 2030)
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospital and Diagnostic Centers
  • Other End Use
  • Regional Outlook (Revenue, USD Million; 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. Electrophoresis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Increasing industry academia collaborations
      • 3.2.1.3. Rising need for personalized medicines
      • 3.2.1.4. Technological advancements
      • 3.2.1.5. Increasing funding for genomics and proteomics research
      • 3.2.1.6. Rising number of clinical laboratories
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Untrained personnel
      • 3.2.2.2. Stringent regulations
  • 3.3. Electrophoresis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Electrophoresis Market: Product Estimates & Trend Analysis

  • 4.1. Global Electrophoresis Market: Product Dashboard
  • 4.2. Global Electrophoresis Market: Product Movement Analysis
  • 4.3. Global Electrophoresis Market by Product , Revenue
  • 4.4. Electrophoresis Reagents
    • 4.4.1. Electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Protein Electrophoresis Reagents
      • 4.4.2.1. Protein electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Nucleic Acid Electrophoresis Reagents
      • 4.4.3.1. Nucleic acid electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Electrophoresis Systems
    • 4.5.1. Electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Gel Electrophoresis Systems
      • 4.5.2.1. Electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Capillary Electrophoresis Systems
      • 4.5.3.1. Capillary electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Gel Documentation Systems
    • 4.6.1. Gel documentation systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Software
    • 4.7.1. Software market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Electrophoresis Market: Application Estimates & Trend Analysis

  • 5.1. Global Electrophoresis Market: Application Dashboard
  • 5.2. Global Electrophoresis Market: Application Movement Analysis
  • 5.3. Global Electrophoresis Market by Application, Revenue
  • 5.4. Research Applications
    • 5.4.1. Research applications market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Diagnostics Applications
    • 5.5.1. Diagnostics applications market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Quality Control and Process Validation
    • 5.6.1. Quality control and process validation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Electrophoresis Market: End Use Estimates & Trend Analysis

  • 6.1. Global Electrophoresis Market: Ens-use Dashboard
  • 6.2. Global Electrophoresis Market: End Use Movement Analysis
  • 6.3. Global Electrophoresis Market by End Use, Revenue
  • 6.4. Academic and Research Institutes
    • 6.4.1. Academic and research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Pharmaceutical and Biotechnology Companies
    • 6.5.1. Pharmaceutical and biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Hospital and Diagnostic Centers
    • 6.6.1. Hospital and diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Other End Use
    • 6.7.1. Other end use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Electrophoresis Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Bio-Rad Laboratories, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Thermo Fisher Scientific Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Agilent Technologies, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Merck KGaA
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. GE Healthcare
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. QIAGEN
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Lonza Group Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. PerkinElmer, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Danaher
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Harvard Bioscience, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Shimadzu Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Oncology Companion Diagnostic, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Oncology Companion Diagnostic, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 9 North America Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 10 North America Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 12 U.S. Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 18 Mexico Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 19 Mexico Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Oncology Companion Diagnostic, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 22 Europe Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 25 Germany Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 27 UK Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 28 UK Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 29 UK Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 31 France Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 32 France Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 34 Italy Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 37 Spain Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 38 Spain Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 40 Denmark Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 41 Denmark Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 43 Sweden Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 46 Norway Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 47 Norway Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Electrophoresis, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 52 China Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 53 China Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 54 China Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Japan Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 56 Japan Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 57 Japan Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 59 India Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 60 India Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 62 South Korea Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 63 South Korea Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Australia Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 65 Australia Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 66 Australia Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 68 Thailand Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 69 Thailand Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Electrophoresis, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 72 Latin America Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 73 Latin America Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 75 Brazil Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 76 Brazil Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 78 Argentina Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Electrophoresis, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 85 South Africa Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 91 UAE Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 92 UAE Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Electrophoresis, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Electrophoresis Market Segmentation
  • FIG. 8 Market Snapshot, 2023
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Global Electrophoresis Market: Product Movement Analysis
  • FIG. 16 Global Electrophoresis Market, for Electrophoresis Reagents, 2018 - 2030 (USD Million)
  • FIG. 17 Global Electrophoresis Market, for Electrophoresis Systems, 2018 - 2030 (USD Million)
  • FIG. 18 Global Electrophoresis Market, for Gel Documentation Systems, 2018 - 2030 (USD Million)
  • FIG. 19 Global Electrophoresis Market, for Software, 2018 - 2030 (USD Million)
  • FIG. 20 Global Electrophoresis Market: Application Movement Analysis
  • FIG. 21 Global Electrophoresis Market, for Research Applications, 2018 - 2030 (USD Million)
  • FIG. 22 Global Electrophoresis Market, for Diagnostics Applications, 2018 - 2030 (USD Million)
  • FIG. 23 Global Electrophoresis Market, for Quality Control and Process Validation, 2018 - 2030 (USD Million)
  • FIG. 24 Global Electrophoresis Market: End Use Movement Analysis
  • FIG. 25 Global Electrophoresis Market, for Academic and Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 26 Global Electrophoresis Market, for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 27 Global Electrophoresis Market, for Hospital and Diagnostic Centers, 2018 - 2030 (USD Million)
  • FIG. 28 Global Electrophoresis Market, for Other End Use, 2018 - 2030 (USD Million)
  • FIG. 29 Regional Marketplace: Key Takeaways
  • FIG. 30 Regional Outlook, 2023 & 2030
  • FIG. 31 Global Electrophoresis Market: Region Movement Analysis
  • FIG. 32 North America Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 33 U.S. Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 34 Canada Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 35 Mexico Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 36 Europe Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 37 Germany Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 38 UK Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 39 France Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 40 Italy Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 41 Spain Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 42 Denmark Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 43 Sweden Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 44 Norway Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 45 Asia Pacific Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 46 Japan Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 47 China Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 48 India Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 49 Australia Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 50 South Korea Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 51 Thailand Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 52 Latin America Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 53 Brazil Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 54 Argentina Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 55 Middle East and Africa Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 56 South Africa Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 57 Saudi Arabia Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 58 UAE Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 59 Kuwait Electrophoresis Market, 2018 - 2030 (USD Million)